PAYS Paysign Inc

Paysign to Host Third Quarter 2024 Earnings Call

Paysign, Inc. (NASDAQ: ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss its third quarter 2024 financial results at 5:00 p.m. Eastern time on Tuesday, November 5, 2024.

Participant details are as follows:

U.S. dial-in: 877.407.2988

International dial-in: +1.201.389.0923

Webcast:

Replay:

Dial-in: 877.660.6853 or +1.201.612.7415

Conference ID: 13749532

The replay will be available until February 5, 2025.

To register as a financial professional in order to ask questions during the call, please email no later than 5:00 p.m. Eastern time on Friday, November 1, 2024.

Forward-Looking Statements

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.

About Paysign

Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign’s end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, gift cards and countless other exchanges of value. Paysign’s solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit .

EN
15/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Paysign Inc

 PRESS RELEASE

Paysign to Host Fourth Quarter and Full Year 2024 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss fourth quarter and full year 2024 earnings at 5:00 p.m. ET on Tuesday, March 25, 2025. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Replay: Dial-in: 877.660.6853 or +1.201.612.7415 Conference ID: 13752001 The replay will be available until June 25, 2025. To register as a financial professional in ord...

 PRESS RELEASE

Paysign Announces 2024 Performance Analysis of Patient Affordability S...

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: ), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced its annual performance analysis of pharmaceutical copay programs leveraging their patient affordability solutions. Paysign’s dynamic business rules feature, which the company introduced in 2022 to mitigate the harmful financial impact of copay maximizers on both patients and pharmaceutical program sponsors, saved their clients more than $100 million in 2024 alone. Due to its ability to iden...

 PRESS RELEASE

Paysign, Inc. Reports Third Quarter 2024 Financial Results

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the third quarter 2024. “We are pleased to report strong third-quarter results, achieving 23.0% revenue growth and a 20.6% increase in adjusted EBITDA,” said Mark Newcomer, President & CEO of Paysign. “Revenue from patient affordability programs rose by 219.1% year-over-year, and we ended the quarter with 66 active programs. Gross margins also sa...

 PRESS RELEASE

Paysign to Host Third Quarter 2024 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss its third quarter 2024 financial results at 5:00 p.m. Eastern time on Tuesday, November 5, 2024. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Replay: Dial-in: 877.660.6853 or +1.201.612.7415 Conference ID: 13749532 The replay will be available until February 5, 2025. To register as a financial professio...

 PRESS RELEASE

Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtu...

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: ), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, today announced their participation in the Sidoti Micro-Cap Virtual Conference, taking place August 14-15, 2024. Jeff Baker, Paysign’s Chief Financial Officer, will be available for one-on-one and small group meetings with investors during the event. Paysign is scheduled for a group presentation on Wednesday, August 14, at 4:00 p.m. EDT. To register or learn more about the confer...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch